Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGD | P52209 | 3/20 | 0.55 |
| ▸ | PGK1 | P00558 | 1/20 | 0.48 |
| ▸ | PGK2 | P07205 | 1/20 | 0.48 |
| ▸ | MPI | P34949 | 1/20 | 0.46 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.33 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.33 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.33 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.33 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL321570 | 0.96 | PGD (0.55) | PGDPGK1PGK2MPILPAR6 | |
| SCHEMBL2619139 | 0.96 | PGD (0.55) | PGDPGK1PGK2MPILPAR6 | |
| SCHEMBL666269 | 0.89 | PGD (0.58) | PGDPGK1PGK2MPILPAR6 | |
| SCHEMBL12189551 | 0.89 | PGD (0.58) | PGDPGK1PGK2MPILPAR6 | |
| SCHEMBL30899166 | 0.89 | PGD (0.58) | PGDPGK1PGK2MPILPAR6 | |
| SCHEMBL23888257 | 0.89 | PGD (0.58) | PGDPGK1PGK2MPILPAR6 | |
| SCHEMBL28247642 | 0.86 | MPI (0.66) | PGDPGK1PGK2MPI | |
| SCHEMBL29550870 | 0.85 | PGD (0.54) | PGDPGK1PGK2MPI | |
| Pyruvate SCHEMBL28989557 | 0.83 | PGD (0.51) | PGDPGK1PGK2MPILPAR6 | |
| SCHEMBL16416132 | 0.82 | PGD (0.61) | PGDPGK1PGK2MPILPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4702138-A1 | PRODUCTION OF A NEGATIVELY CHARGED OLIGOSACCHARIDE BY A CELL | Inbiose N.V. (BE) | 2026-03-04 | — | — | EP | claimed |
| WO-2024223815-A1 | PRODUCTION OF A NEGATIVELY CHARGED OLIGOSACCHARIDE BY A CELL | INBIOSE N.V. (BE) | 2024-10-31 | — | — | WO | claimed |
| EP-4731778-A2 | SIALYLTRANSFERASES FOR THE PRODUCTION OF SIALYLATED OLIGOSACCHARIDES | Inbiose N.V. (BE) | 2026-04-29 | — | — | EP | disclosed |
| EP-4727928-A1 | METHOD FOR PRODUCING AROMATIC THIAZINES OR SELENAZINES | Universität Heidelberg (DE) | 2026-04-22 | — | — | EP | disclosed |
| EP-4702138-A1 | PRODUCTION OF A NEGATIVELY CHARGED OLIGOSACCHARIDE BY A CELL | Inbiose N.V. (BE) | 2026-03-04 | — | — | EP | disclosed |
| EP-4651963-A1 | PURIFICATION OF AN OLIGOSACCHARIDE OR OLIGOSACCHARIDE MIXTURE | Inbiose N.V. (BE) | 2025-11-26 | — | — | EP | disclosed |
| WO-2025224348-A1 | PRODUCTION OF A MILK OLIGOSACCHARIDE MIXTURE | INBIOSE N.V. (BE) | 2025-10-30 | — | — | WO | disclosed |
| US-12344875-B2 | Sialyltransferases for the production of sialylated oligosaccharides | INBIOSE N.V. (BE) | 2025-07-01 | — | — | US | disclosed |
| WO-2025088102-A1 | PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE COMPRISING GAL-β1,3-[NEU5AC-A2,6]-HEXNAC-R | INBIOSE N.V. (BE) | 2025-05-01 | — | — | WO | disclosed |
| WO-2025088103-A1 | PRODUCTION OF A SIALYLATED COMPOUND | INBIOSE N.V. (BE) | 2025-05-01 | — | — | WO | disclosed |
| US-20250109419-A1 | SIALYLTRANSFERASES FOR THE PRODUCTION OF SIALYLATED OLIGOSACCHARIDES | INBIOSE N.V. (BE) | 2025-04-03 | — | — | US | disclosed |
| EP-1987137-B1 | SYNTHESIS OF SIALIC ACID IN PLANTS | MEDICAGO INC (CA) | 2011-06-22 | — | — | EP | disclosed |
| EP-2224009-A1 | Synthesis of sialic acid in plants | Medicago Inc. (CA) | 2010-09-01 | — | — | EP | disclosed |
| US-20090312240-A1 | Synthesis of Sialic Acid in Plants | MEDICAGO INC. (CA) | 2009-12-17 | — | — | US | disclosed |
| CN-101466829-A | Synthesis of sialic acid in plants | MEDICAGO INC (CA) | 2009-06-24 | — | — | CN | disclosed |
| EP-2036562-A1 | A1 adenosine receptor antagonist for preventing and treating tissue injury and sepsis associated with yersinia pestis infection | Endacea, Inc. (US) | 2009-03-18 | — | — | EP | disclosed |
| EP-1987137-A1 | SYNTHESIS OF SIALIC ACID IN PLANTS | Medicago Inc. (CA) | 2008-11-05 | — | — | EP | disclosed |
| WO-2007090290-A1 | SYNTHESIS OF SIALIC ACID IN PLANTS | MEDICAGO INC. (CA) | 2007-08-16 | — | — | WO | disclosed |
| WO-2002078634-A3 | METHODS FOR USING KDOP AND KDOP SYNTHASE INHIBITORS FOR THE TREATMENT OF BACTERIAL INFECTION | FAZIX CORP (US) | 2003-05-01 | — | — | WO | disclosed |
| WO-2002078634-A2 | METHODS FOR USING KDOP AND KDOP SYNTHASE INHIBITORS FOR THE TREATMENT OF BACTERIAL INFECTION | FAZIX CORPORATION (US) | 2002-10-10 | — | — | WO | disclosed |